Avalo Therapeutics (AVTX) Amortization - Intangibles (2017 - 2022)
Avalo Therapeutics (AVTX) reported Amortization - Intangibles of $38000.0 for Q1 2022, down 91.04% on a YoY basis from $424000.0 in Q1 2021, and down 85.77% quarter-over-quarter from $267000.0 in Q4 2021.
Avalo Therapeutics (AVTX) Amortization - Intangibles (2017 - 2022) Analysis & Trends
Avalo Therapeutics has reported Amortization - Intangibles for 6 years, with the latest figure at $38000.0 in Q1 2022.
- For the quarter ending Q1 2022, Amortization - Intangibles fell 91.04% year-over-year to $38000.0; the trailing twelve-month figure through Dec 2022 stood at $38000.0 (down 97.54% YoY), and the FY2022 full-year result was $38000.0, down 97.55% from the prior year.
- Amortization - Intangibles for Q1 2022 stood at $38000.0, down from $267000.0 in the prior quarter.
- The five-year high for Amortization - Intangibles was $1.2 million in Q2 2018, with the low at -$1.5 million in Q4 2018.
- Historically, Amortization - Intangibles has averaged $382032.1 across 5 years, with a median of $404000.0 in 2020.
- Annual changes were most pronounced in 2018 — Amortization - Intangibles slumped 468.58% — and 2019, when it soared 122.51%.
- Avalo Therapeutics' Amortization - Intangibles stood at -$1.5 million in 2018, then soared by 122.51% to $334753.0 in 2019, then soared by 50.26% to $503000.0 in 2020, then sank by 46.92% to $267000.0 in 2021, then slumped by 85.77% to $38000.0 in 2022.
- The last three Amortization - Intangibles figures came in at $38000.0 (Q1 2022), $267000.0 (Q4 2021), and $428000.0 (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Avalo Therapeutics | 295.77 Mn | 295.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 38,000.00 |
| Dec 31, 2021 | 267,000.00 |
| Sep 30, 2021 | 428,000.00 |
| Jun 30, 2021 | 428,000.00 |
| Mar 31, 2021 | 424,000.00 |
| Dec 31, 2020 | 503,000.00 |
| Sep 30, 2020 | 404,000.00 |
| Jun 30, 2020 | 404,000.00 |
| Mar 31, 2020 | 431,000.00 |
| Dec 31, 2019 | 334,753.00 |
| Sep 30, 2019 | 334,748.00 |
| Jun 30, 2019 | 334,747.00 |
| Mar 31, 2019 | 334,748.00 |
| Dec 31, 2018 | -1.49 Mn |
| Sep 30, 2018 | 1.07 Mn |
| Jun 30, 2018 | 1.23 Mn |
| Mar 31, 2018 | 1.02 Mn |
| Dec 31, 2017 | 403,520.00 |